Phase
Condition
Neurologic Disorders
Treatment
Sensorimotor Training Exercise
Conventional Exercise Therapy
Clinical Study ID
Ages 30-65 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Females with invasive ductal carcinoma, stages I-III
Age ranged between 30-65 years
3-6 months post breast cancer diagnosis
Those who have completed chemotherapy treatment and are medically stable
CIPN symptoms as subjectively assessed by FACT/GOG-Ntx. Score ranges from 0-44 (5). 0 - 10: Minimal or no neurotoxicity symptoms, 11 - 20: Mild neurotoxicity symptoms, 21 - 30: Moderate neurotoxicity symptoms, 31 - 40: Severe neurotoxicity symptoms, 41
44: Very severe neurotoxicity symptoms
For balance testing Fullerton Advanced Balance (FAB) scale was used. 0-19 = highrisk of falls, 20-29 = moderate balance impairment, 30-40 = good balance. The cutoff value is ≤ 25/40 Points.
Objective neurological testing such as Achilles and patellar tendon reflexes (1 =agile, 2 = weak, 3 = missing), peripheral deep sensitivity (0=no sensitivity to 8=highest sensitivity), light touch perception (symmetrical or impaired), sense ofposition (1 = position recognized, 2 = only position of knee recognized, and 3 = norecognition) and lower leg strength (0 = no activity to 5 = normal force) rated on aLikert-scale
Exclusion
Exclusion Criteria:
Women with additional types of cancer besides breast cancer
Chronic medical conditions such as poorly controlled diabetes (6)
Significant neurological (multiple sclerosis) or cardiopulmonary disease (myocardialinfarction < 3 months) that may affect performance (6)
Unstable bone metastasis
Study Design
Study Description
Connect with a study center
Mayo Hospital
Lahore, Punjab 54000
PakistanActive - Recruiting
Mayo Hospital Lahore
Lahore, Punjab 54000
PakistanActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.